Glenmark Pharmaceuticals Limited
Records under this name other than the patents Glenmark Pharmaceuticals Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
Back to Glenmark Pharmaceuticals Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,097,729 | Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US D795,414 | Inhaler Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,227,958 | Amorphous and crystalline forms of aprepitant and processes for the preparation thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,670,160 | Process for the preparation of tofacitinib and intermediates thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,550,735 | Process for the preparation of ivacaftor and solvates thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,078,923 | Stable Fixed Dose Pharmaceutical Composition Comprising Mometasone and Olopatadine Formerly held In force · High confidence | In force | High confidence | |
| US 9,370,483 | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,646,500 | Treatment of Allergic Rhinitis Using a Combination of Mometasone and Olopatadine Formerly held In force · High confidence | In force | High confidence | |
| US 9,840,456 | Process for preparation of dimethyl fumarate Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,548,907 | Treatment of allergic rhinitis using a combination of mometasone and olopatadine Formerly held In force · From the USPTO record | In force | From the USPTO record |